Contemporary Oncology (Mar 2022)

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients

  • Lobna A. Abdelaziz,
  • Huda Ebian,
  • Ola Harb,
  • Yousef Nosery,
  • Heba Taha,
  • Nashwa Nawar

DOI
https://doi.org/10.5114/wo.2022.115678
Journal volume & issue
Vol. 26, no. 1
pp. 78 – 87

Abstract

Read online

No abstracts available.

Keywords